{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T17:45:57Z","timestamp":1794851157019,"version":"4.9.1"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T00:00:00Z","timestamp":1641772800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T00:00:00Z","timestamp":1641772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Oxylipins are potent biological mediators requiring strict control, but how they are removed en masse during infection and inflammation is unknown. Here we show that lipopolysaccharide (LPS) dynamically enhances oxylipin removal via mitochondrial \u03b2-oxidation. Specifically, genetic or pharmacological targeting of carnitine palmitoyl transferase 1 (CPT1), a mitochondrial importer of fatty acids, reveal that many oxylipins are removed by this protein during inflammation in vitro and in vivo. Using stable isotope-tracing lipidomics, we find secretion-reuptake recycling for 12-HETE and its intermediate metabolites. Meanwhile, oxylipin \u03b2-oxidation is uncoupled from oxidative phosphorylation, thus not contributing to energy generation. Testing for genetic control checkpoints, transcriptional interrogation of human neonatal sepsis finds upregulation of many genes involved in mitochondrial removal of long-chain fatty acyls, such as\n                    <jats:italic>ACSL1,3,4, ACADVL, CPT1B, CPT2<\/jats:italic>\n                    and\n                    <jats:italic>HADHB<\/jats:italic>\n                    . Also,\n                    <jats:italic>ACSL1\/Acsl1<\/jats:italic>\n                    upregulation is consistently observed following the treatment of human\/murine macrophages with LPS and IFN-\u03b3. Last, dampening oxylipin levels by \u03b2-oxidation is suggested to impact on their regulation of leukocyte functions. In summary, we propose mitochondrial \u03b2-oxidation as a regulatory metabolic checkpoint for oxylipins during inflammation.\n                  <\/jats:p>","DOI":"10.1038\/s41467-021-27766-8","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T06:02:59Z","timestamp":1641794579000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":101,"title":["Oxylipin metabolism is controlled by mitochondrial \u03b2-oxidation during bacterial inflammation"],"prefix":"10.1038","volume":"13","author":[{"given":"Mariya","family":"Misheva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6846-7761","authenticated-orcid":false,"given":"Konstantinos","family":"Kotzamanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke C.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria J.","family":"Tyrrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0768-0013","authenticated-orcid":false,"given":"Patricia R. S.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria A.","family":"Benavides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Hinz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0163-1421","authenticated-orcid":false,"given":"Philip R.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Rosas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon A.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7021-5934","authenticated-orcid":false,"given":"James E.","family":"McLaren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumukh","family":"Deshpande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils Helge","family":"Schebb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena A.","family":"Czubala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1119-6638","authenticated-orcid":false,"given":"Mark","family":"Gurney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maceler","family":"Aldrovandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven W.","family":"Meckelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0035-2228","authenticated-orcid":false,"given":"Peter","family":"Ghazal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Darley-Usmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7588-8935","authenticated-orcid":false,"given":"Daniel A.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4089-8460","authenticated-orcid":false,"given":"Valerie B.","family":"O\u2019Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,10]]},"reference":[{"key":"27766_CR1","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1126\/science.294.5548.1871","volume":"294","author":"CD Funk","year":"2001","unstructured":"Funk, C. D. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294, 1871\u20131875 (2001).","journal-title":"Science"},{"key":"27766_CR2","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1124\/pr.56.3.3","volume":"56","author":"DL Simmons","year":"2004","unstructured":"Simmons, D. L., Botting, R. M. & Hla, T. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharm. Rev. 56, 387\u2013437 (2004).","journal-title":"Pharm. Rev."},{"key":"27766_CR3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev.biochem.69.1.145","volume":"69","author":"WL Smith","year":"2000","unstructured":"Smith, W. L., DeWitt, D. L. & Garavito, R. M. Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev. Biochem. 69, 145\u2013182 (2000).","journal-title":"Annu Rev. Biochem."},{"key":"27766_CR4","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nri2294","volume":"8","author":"CN Serhan","year":"2008","unstructured":"Serhan, C. N., Chiang, N. & Van Dyke, T. E. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 8, 349\u2013361 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"27766_CR5","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/sj.ki.5002394","volume":"72","author":"JH Capdevila","year":"2007","unstructured":"Capdevila, J. H., Falck, J. R. & Imig, J. D. Roles of the cytochrome P450 arachidonic acid monooxygenases in the control of systemic blood pressure and experimental hypertension. Kidney Int. 72, 683\u2013689 (2007).","journal-title":"Kidney Int."},{"key":"27766_CR6","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.tips.2007.08.002","volume":"28","author":"I Fleming","year":"2007","unstructured":"Fleming, I. DiscrEET regulators of homeostasis: epoxyeicosatrienoic acids, cytochrome P450 epoxygenases and vascular inflammation. Trends Pharm. Sci. 28, 448\u2013452 (2007).","journal-title":"Trends Pharm. Sci."},{"key":"27766_CR7","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/FJC.0b013e3181e96e0c","volume":"56","author":"JD Imig","year":"2010","unstructured":"Imig, J. D. Targeting epoxides for organ damage in hypertension. J. Cardiovasc. Pharm. 56, 329\u2013335 (2010).","journal-title":"J. Cardiovasc. Pharm."},{"key":"27766_CR8","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1152\/physrev.00021.2001","volume":"82","author":"RJ Roman","year":"2002","unstructured":"Roman, R. J. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol. Rev. 82, 131\u2013185 (2002).","journal-title":"Physiol. Rev."},{"key":"27766_CR9","doi-asserted-by":"publisher","first-page":"C996","DOI":"10.1152\/ajpcell.00402.2006","volume":"292","author":"AA Spector","year":"2007","unstructured":"Spector, A. A. & Norris, A. W. Action of epoxyeicosatrienoic acids on cellular function. Am. J. Physiol. Cell Physiol. 292, C996\u2013C1012 (2007).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"27766_CR10","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1097\/FJC.0b013e3181f04b1c","volume":"56","author":"JM Williams","year":"2010","unstructured":"Williams, J. M. et al. 20-hydroxyeicosatetraeonic acid: a new target for the treatment of hypertension. J. Cardiovasc. Pharm. 56, 336\u2013344 (2010).","journal-title":"J. Cardiovasc. Pharm."},{"key":"27766_CR11","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1146\/annurev.pharmtox.41.1.661","volume":"41","author":"RM Breyer","year":"2001","unstructured":"Breyer, R. M. et al. Prostanoid receptors: subtypes and signaling. Annu. Rev. Pharm. Toxicol. 41, 661\u2013690. (2001).","journal-title":"Annu. Rev. Pharm. Toxicol."},{"key":"27766_CR12","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1161\/01.HYP.0000116221.27079.ea","volume":"43","author":"HF Cheng","year":"2004","unstructured":"Cheng, H. F. & Harris, R. C. Cyclooxygenases, the kidney, and hypertension. Hypertension 43, 525\u2013530 (2004).","journal-title":"Hypertension"},{"key":"27766_CR13","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1146\/annurev.physiol.70.113006.100614","volume":"70","author":"CM Hao","year":"2008","unstructured":"Hao, C. M. & Breyer, M. D. Physiological regulation of prostaglandins in the kidney. Annu. Rev. Physiol. 70, 357\u2013377. (2008).","journal-title":"Annu. Rev. Physiol."},{"key":"27766_CR14","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/med.20071","volume":"27","author":"V Capra","year":"2007","unstructured":"Capra, V. et al. Cysteinyl-leukotrienes and their receptors in asthma and other inflammatory diseases: critical update and emerging trends. Med. Res. Rev. 27, 469\u2013527 (2007).","journal-title":"Med. Res. Rev."},{"key":"27766_CR15","doi-asserted-by":"publisher","first-page":"S213","DOI":"10.2223\/JPED.1553","volume":"82","author":"JD Ribeiro","year":"2006","unstructured":"Ribeiro, J. D., Toro, A. A. & Baracat, E. C. Antileukotrienes in the treatment of asthma and allergic rhinitis. J. Pediatr. (Rio J.) 82, S213\u2013S221 (2006).","journal-title":"J. Pediatr. (Rio J.)"},{"key":"27766_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s10787-006-1496-6","volume":"14","author":"JN Sharma","year":"2006","unstructured":"Sharma, J. N. & Mohammed, L. A. The role of leukotrienes in the pathophysiology of inflammatory disorders: is there a case for revisiting leukotrienes as therapeutic targets? Inflammopharmacology 14, 10\u201316 (2006).","journal-title":"Inflammopharmacology"},{"key":"27766_CR17","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1172\/JCI115401","volume":"88","author":"U Diczfalusy","year":"1991","unstructured":"Diczfalusy, U. et al. Metabolism of prostaglandin F2 alpha in Zellweger syndrome. Peroxisomal beta-oxidation is a major importance for in vivo degradation of prostaglandins in humans. J. Clin. Invest. 88, 978\u2013984 (1991).","journal-title":"J. Clin. Invest."},{"key":"27766_CR18","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/S0022-2275(20)39986-7","volume":"34","author":"J Wigren","year":"1993","unstructured":"Wigren, J. et al. Metabolism of 12(S)-hydroxy-5,8,10,14-eicosatetraenoic acid by kidney and liver peroxisomes. J. Lipid Res. 34, 625\u2013631 (1993).","journal-title":"J. Lipid Res."},{"key":"27766_CR19","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/0163-7827(94)90025-6","volume":"33","author":"U Diczfalusy","year":"1994","unstructured":"Diczfalusy, U. Beta-oxidation of eicosanoids. Prog. Lipid Res. 33, 403\u2013428. (1994).","journal-title":"Prog. Lipid Res."},{"key":"27766_CR20","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0163-7827(88)90009-4","volume":"27","author":"AA Spector","year":"1988","unstructured":"Spector, A. A., Gordon, J. A. & Moore, S. A. Hydroxyeicosatetraenoic acids (HETEs). Prog. Lipid Res. 27, 271\u2013323 (1988).","journal-title":"Prog. Lipid Res."},{"key":"27766_CR21","unstructured":"Benedetto, C., McDonald-Gibson, R. G., Nigam, S., & Slater, T. F. Prostaglandins and Related Substances: A Practical Approach. 1988 (Oxford, Washington: IRL Press, 1987)."},{"key":"27766_CR22","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1042\/bj3200345","volume":"320","author":"S Eaton","year":"1996","unstructured":"Eaton, S., Bartlett, K. & Pourfarzam, M. Mammalian mitochondrial beta-oxidation. Biochem. J. 320, 345\u2013357 (1996).","journal-title":"Biochem. J."},{"key":"27766_CR23","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1042\/bj2640047","volume":"264","author":"HY Wang","year":"1989","unstructured":"Wang, H. Y. & Schulz, H. Beta-oxidation of polyunsaturated fatty acids with conjugated double bonds. Mitochondrial metabolism of octa-2,4,6-trienoic acid. Biochem. J. 264, 47\u201352 (1989).","journal-title":"Biochem. J."},{"key":"27766_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1146\/annurev-physiol-021115-105045","volume":"78","author":"SM Houten","year":"2016","unstructured":"Houten, S. M. et al. The biochemistry and physiology of mitochondrial fatty acid beta-oxidation and its genetic disorders. Annu. Rev. Physiol. 78, 23\u201344 (2016).","journal-title":"Annu. Rev. Physiol."},{"key":"27766_CR25","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.smim.2016.10.002","volume":"28","author":"MM Kaminski","year":"2016","unstructured":"Kaminski, M. M. et al. Polarization and asymmetry in T cell metabolism. Semin. Immunol. 28, 525\u2013534 (2016).","journal-title":"Semin. Immunol."},{"key":"27766_CR26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1084\/jem.20151570","volume":"213","author":"LA O\u2019Neill","year":"2016","unstructured":"O\u2019Neill, L. A. & Pearce, E. J. Immunometabolism governs dendritic cell and macrophage function. J. Exp. Med. 213, 15\u201323 (2016).","journal-title":"J. Exp. Med."},{"key":"27766_CR27","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.cmet.2016.04.001","volume":"23","author":"DA Slatter","year":"2016","unstructured":"Slatter, D. A. et al. Mapping the human platelet lipidome reveals cytosolic phospholipase A2 as a regulator of mitochondrial bioenergetics during activation. Cell Metab. 23, 930\u2013944 (2016).","journal-title":"Cell Metab."},{"key":"27766_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14433-7","volume":"11","author":"EM Palmieri","year":"2020","unstructured":"Palmieri, E. M. et al. Nitric oxide orchestrates metabolic rewiring in M1 macrophages by targeting aconitase 2 and pyruvate dehydrogenase. Nat. Commun. 11, 698 (2020).","journal-title":"Nat. Commun."},{"key":"27766_CR29","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nri.2016.70","volume":"16","author":"LA O\u2019Neill","year":"2016","unstructured":"O\u2019Neill, L. A., Kishton, R. J. & Rathmell, J. A guide to immunometabolism for immunologists. Nat. Rev. Immunol. 16, 553\u2013565 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"27766_CR30","doi-asserted-by":"publisher","first-page":"360","DOI":"10.5483\/BMBRep.2019.52.6.140","volume":"52","author":"B Thapa","year":"2019","unstructured":"Thapa, B. & Lee, K. Metabolic influence on macrophage polarization and pathogenesis. BMB Rep. 52, 360\u2013372 (2019).","journal-title":"BMB Rep."},{"key":"27766_CR31","doi-asserted-by":"publisher","first-page":"6514","DOI":"10.4049\/jimmunol.181.9.6514","volume":"181","author":"V Dioszeghy","year":"2008","unstructured":"Dioszeghy, V. et al. 12\/15-Lipoxygenase regulates the inflammatory response to bacterial products in vivo. J. Immunol. 181, 6514\u20136524 (2008).","journal-title":"J. Immunol."},{"key":"27766_CR32","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1161\/01.ATV.16.12.1488","volume":"16","author":"JA Cornicelli","year":"1996","unstructured":"Cornicelli, J. A. et al. Mouse peritoneal macrophages contain abundant omega-6 lipoxygenase activity that is independent of interleukin-4. Arterioscler. Thromb. Vasc. Biol. 16, 1488\u20131494 (1996).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"27766_CR33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","volume":"41","author":"PJ Murray","year":"2014","unstructured":"Murray, P. J. et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 41, 14\u201320 (2014).","journal-title":"Immunity"},{"key":"27766_CR34","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1194\/jlr.M081448","volume":"59","author":"T Kriska","year":"2018","unstructured":"Kriska, T. et al. Deactivation of 12(S)-HETE through (omega-1)-hydroxylation and beta-oxidation in alternatively activated macrophages. J. Lipid Res. 59, 615\u2013624 (2018).","journal-title":"J. Lipid Res."},{"key":"27766_CR35","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1084\/jem.155.6.1653","volume":"155","author":"NA Pawlowski","year":"1982","unstructured":"Pawlowski, N. A. et al. Uptake and metabolism of monohydroxy-eicosatetraenoic acids by macrophages. J. Exp. Med. 155, 1653\u20131664 (1982).","journal-title":"J. Exp. Med."},{"key":"27766_CR36","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.cmet.2018.06.001","volume":"28","author":"AS Divakaruni","year":"2018","unstructured":"Divakaruni, A. S. et al. Etomoxir inhibits macrophage polarization by disrupting CoA homeostasis. Cell Metab. 28, 490\u2013503.e7 (2018).","journal-title":"Cell Metab."},{"key":"27766_CR37","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.cmet.2018.06.002","volume":"28","author":"B Raud","year":"2018","unstructured":"Raud, B. et al. Etomoxir actions on regulatory and memory T cells are independent of Cpt1a-mediated fatty acid oxidation. Cell Metab. 28, 504\u2013515.e7 (2018).","journal-title":"Cell Metab."},{"key":"27766_CR38","doi-asserted-by":"publisher","first-page":"e2003782","DOI":"10.1371\/journal.pbio.2003782","volume":"16","author":"C-H Yao","year":"2018","unstructured":"Yao, C.-H. et al. Identifying off-target effects of etomoxir reveals that carnitine palmitoyltransferase I is essential for cancer cell proliferation independent of \u03b2-oxidation. PLoS Biol. 16, e2003782 (2018).","journal-title":"PLoS Biol."},{"key":"27766_CR39","doi-asserted-by":"publisher","first-page":"16212","DOI":"10.1073\/pnas.0604567103","volume":"103","author":"J Zhang","year":"2006","unstructured":"Zhang, J., Frerman, F. E. & Kim, J. J. Structure of electron transfer flavoprotein-ubiquinone oxidoreductase and electron transfer to the mitochondrial ubiquinone pool. Proc. Natl Acad. Sci. USA. 103, 16212\u201316217 (2006).","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"27766_CR40","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.immuni.2015.02.005","volume":"42","author":"AK Jha","year":"2015","unstructured":"Jha, A. K. et al. Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. Immunity 42, 419\u2013430 (2015).","journal-title":"Immunity"},{"key":"27766_CR41","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1002\/1873-3468.12744","volume":"591","author":"DG Ryan","year":"2017","unstructured":"Ryan, D. G. & O\u2019Neill, L. A. J. Krebs cycle rewired for macrophage and dendritic cell effector functions. FEBS Lett. 591, 2992\u20133006 (2017).","journal-title":"FEBS Lett."},{"key":"27766_CR42","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1074\/jbc.M110.154971","volume":"286","author":"X Qian","year":"2011","unstructured":"Qian, X., Zhang, J. & Liu, J. Tumor-secreted PGE2 inhibits CCL5 production in activated macrophages through cAMP\/PKA signaling pathway. J. Biol. Chem. 286, 2111\u20132120 (2011).","journal-title":"J. Biol. Chem."},{"key":"27766_CR43","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.3389\/fmicb.2018.02447","volume":"9","author":"AEF Sheppe","year":"2018","unstructured":"Sheppe, A. E. F. et al. PGE2 augments inflammasome activation and M1 polarization in macrophages infected with Salmonella Typhimurium and Yersinia enterocolitica. Front Microbiol. 9, 2447 (2018).","journal-title":"Front Microbiol."},{"key":"27766_CR44","doi-asserted-by":"publisher","first-page":"6981","DOI":"10.4049\/jimmunol.0901045","volume":"183","author":"D Strassheim","year":"2009","unstructured":"Strassheim, D. et al. Prostacyclin inhibits IFN-gamma-stimulated cytokine expression by reduced recruitment of CBP\/p300 to STAT1 in a SOCS-1-independent manner. J. Immunol. 183, 6981\u20136988 (2009).","journal-title":"J. Immunol."},{"key":"27766_CR45","doi-asserted-by":"publisher","first-page":"44147","DOI":"10.1074\/jbc.M204810200","volume":"277","author":"K Takayama","year":"2002","unstructured":"Takayama, K. et al. Prostaglandin E2 suppresses chemokine production in human macrophages through the EP4 receptor. J. Biol. Chem. 277, 44147\u201344154 (2002).","journal-title":"J. Biol. Chem."},{"key":"27766_CR46","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3389\/fimmu.2018.00893","volume":"9","author":"M Heming","year":"2018","unstructured":"Heming, M. et al. Peroxisome proliferator-activated receptor-\u03b3 modulates the response of macrophages to lipopolysaccharide and glucocorticoids. Front. Immunol. 9, 893 (2018).","journal-title":"Front. Immunol."},{"key":"27766_CR47","doi-asserted-by":"publisher","first-page":"eaar8320","DOI":"10.1126\/sciadv.aar8320","volume":"4","author":"CA Loynes","year":"2018","unstructured":"Loynes, C. A. et al. PGE2 production at sites of tissue injury promotes an anti-inflammatory neutrophil phenotype and determines the outcome of inflammation resolution in vivo. Sci. Adv. 4, eaar8320 (2018).","journal-title":"Sci. Adv."},{"key":"27766_CR48","doi-asserted-by":"publisher","first-page":"3474","DOI":"10.4049\/jimmunol.1900201","volume":"202","author":"MG Pitts","year":"2019","unstructured":"Pitts, M. G. & D\u2019Orazio, S. E. F. Prostaglandin E2 inhibits the ability of neutrophils to kill Listeria monocytogenes. J. Immunol. 202, 3474\u20133482 (2019).","journal-title":"J. Immunol."},{"key":"27766_CR49","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.phrs.2017.10.009","volume":"128","author":"J Avila-Roman","year":"2018","unstructured":"Avila-Roman, J. et al. Microalgae-derived oxylipins decrease inflammatory mediators by regulating the subcellular location of NFkappaB and PPAR-gamma. Pharm. Res 128, 220\u2013230 (2018).","journal-title":"Pharm. Res"},{"key":"27766_CR50","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1084\/jem.2006183905142018c","volume":"215","author":"SE Dunn","year":"2018","unstructured":"Dunn, S. E. et al. Correction: peroxisome proliferator-activated receptor (PPAR)alpha expression in T cells mediates gender differences in development of T cell-mediated autoimmunity. J. Exp. Med. 215, 1765 (2018).","journal-title":"J. Exp. Med."},{"key":"27766_CR51","doi-asserted-by":"publisher","first-page":"3383","DOI":"10.4049\/jimmunol.0900327","volume":"183","author":"G Kronke","year":"2009","unstructured":"Kronke, G. et al. 12\/15-Lipoxygenase counteracts inflammation and tissue damage in arthritis. J. Immunol. 183, 3383\u20133389 (2009).","journal-title":"J. Immunol."},{"key":"27766_CR52","doi-asserted-by":"publisher","first-page":"31649","DOI":"10.1038\/srep31649","volume":"6","author":"N Kumar","year":"2016","unstructured":"Kumar, N. et al. 15-Lipoxygenase metabolites of alpha-linolenic acid, [13-(S)-HPOTrE and 13-(S)-HOTrE], mediate anti-inflammatory effects by inactivating NLRP3 inflammasome. Sci. Rep. 6, 31649 (2016).","journal-title":"Sci. Rep."},{"key":"27766_CR53","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1194\/jlr.M053058","volume":"56","author":"L Sun","year":"2015","unstructured":"Sun, L. et al. 12\/15-Lipoxygenase metabolites of arachidonic acid activate PPARgamma: a possible neuroprotective effect in ischemic brain. J. Lipid Res. 56, 502\u2013514. (2015).","journal-title":"J. Lipid Res."},{"key":"27766_CR54","doi-asserted-by":"publisher","first-page":"5868","DOI":"10.1074\/jbc.M114.635151","volume":"290","author":"SG Wendell","year":"2015","unstructured":"Wendell, S. G. et al. 15-Hydroxyprostaglandin dehydrogenase generation of electrophilic lipid signaling mediators from hydroxy omega-3 fatty acids. J. Biol. Chem. 290, 5868\u20135880 (2015).","journal-title":"J. Biol. Chem."},{"key":"27766_CR55","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1194\/jlr.M047514","volume":"55","author":"H Yamada","year":"2014","unstructured":"Yamada, H. et al. Hydroxyeicosapentaenoic acids from the Pacific krill show high ligand activities for PPARs. J. Lipid Res. 55, 895\u2013904 (2014).","journal-title":"J. Lipid Res."},{"key":"27766_CR56","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/S1074-7613(01)00151-0","volume":"14","author":"SM Hurst","year":"2001","unstructured":"Hurst, S. M. et al. Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity 14, 705\u2013714 (2001).","journal-title":"Immunity"},{"key":"27766_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5649","volume":"5","author":"CL Smith","year":"2014","unstructured":"Smith, C. L. et al. Identification of a human neonatal immune-metabolic network associated with bacterial infection. Nat. Commun. 5, 4649 (2014).","journal-title":"Nat. Commun."},{"key":"27766_CR58","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.immuni.2013.10.022","volume":"40","author":"CA Fielding","year":"2014","unstructured":"Fielding, C. A. et al. Interleukin-6 signaling drives fibrosis in unresolved inflammation. Immunity 40, 40\u201350 (2014).","journal-title":"Immunity"},{"key":"27766_CR59","doi-asserted-by":"publisher","first-page":"e45466","DOI":"10.1371\/journal.pone.0045466","volume":"7","author":"M Beyer","year":"2012","unstructured":"Beyer, M. et al. High-resolution transcriptome of human macrophages. PLoS One 7, e45466 (2012).","journal-title":"PLoS One"},{"key":"27766_CR60","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/ni.2956","volume":"15","author":"SC Huang","year":"2014","unstructured":"Huang, S. C. et al. Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages. Nat. Immunol. 15, 846\u2013855 (2014).","journal-title":"Nat. Immunol."},{"key":"27766_CR61","doi-asserted-by":"publisher","first-page":"e0145342","DOI":"10.1371\/journal.pone.0145342","volume":"10","author":"KA Jablonski","year":"2015","unstructured":"Jablonski, K. A. et al. Novel markers to delineate murine M1 and M2 macrophages. PLoS One 10, e0145342 (2015).","journal-title":"PLoS One"},{"key":"27766_CR62","doi-asserted-by":"publisher","first-page":"7303","DOI":"10.4049\/jimmunol.177.10.7303","volume":"177","author":"FO Martinez","year":"2006","unstructured":"Martinez, F. O. et al. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J. Immunol. 177, 7303\u20137311 (2006).","journal-title":"J. Immunol."},{"key":"27766_CR63","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/ni.3710","volume":"18","author":"V Piccolo","year":"2017","unstructured":"Piccolo, V. et al. Opposing macrophage polarization programs show extensive epigenomic and transcriptional cross-talk. Nat. Immunol. 18, 530\u2013540 (2017).","journal-title":"Nat. Immunol."},{"key":"27766_CR64","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.immuni.2014.01.006","volume":"40","author":"J Xue","year":"2014","unstructured":"Xue, J. et al. Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity 40, 274\u201388. (2014).","journal-title":"Immunity"},{"key":"27766_CR65","doi-asserted-by":"publisher","first-page":"21048","DOI":"10.1016\/S0021-9258(17)45325-7","volume":"265","author":"SN Mathur","year":"1990","unstructured":"Mathur, S. N., Albright, E. & Field, F. J. 12-Hydroxyeicosatetraenoic acid is metabolized by beta-oxidation in mouse peritoneal macrophages. Identification of products and proposed pathway. J. Biol. Chem. 265, 21048\u201321055 (1990).","journal-title":"J. Biol. Chem."},{"key":"27766_CR66","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1172\/JCI118897","volume":"98","author":"R Lu","year":"1996","unstructured":"Lu, R. et al. Cloning, in vitro expression, and tissue distribution of a human prostaglandin transporter cDNA(hPGT). J. Clin. Invest. 98, 1142\u20131149 (1996).","journal-title":"J. Clin. Invest."},{"key":"27766_CR67","unstructured":"Bennett, M. J. & Santani, A. B. Carnitine palmitoyltransferase 1A deficiency. In GeneReviews((R)) (eds Adam, M. P. et al.) https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1527\/ (Seattle (WA), 1993\u20132021)."},{"key":"27766_CR68","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1542\/peds.2010-0687","volume":"126","author":"BD Gessner","year":"2010","unstructured":"Gessner, B. D. et al. Evidence for an association between infant mortality and a carnitine palmitoyltransferase 1A genetic variant. Pediatrics 126, 945\u2013951 (2010).","journal-title":"Pediatrics"},{"key":"27766_CR69","doi-asserted-by":"publisher","first-page":"e111","DOI":"10.1093\/pch\/pxy106","volume":"24","author":"G Sinclair","year":"2019","unstructured":"Sinclair, G. et al. The p.P479L variant in CPT1A is associated with infectious disease in a BC First Nation. Paediatr. Child Health 24, e111\u2013e115 (2019).","journal-title":"Paediatr. Child Health"},{"key":"27766_CR70","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.cmet.2010.05.012","volume":"12","author":"JM Ellis","year":"2010","unstructured":"Ellis, J. M. et al. Adipose acyl-CoA synthetase-1 directs fatty acids toward beta-oxidation and is required for cold thermogenesis. Cell Metab. 12, 53\u201364 (2010).","journal-title":"Cell Metab."},{"key":"27766_CR71","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1128\/MCB.01085-10","volume":"31","author":"JM Ellis","year":"2011","unstructured":"Ellis, J. M. et al. Mouse cardiac acyl coenzyme a synthetase 1 deficiency impairs fatty acid oxidation and induces cardiac hypertrophy. Mol. Cell Biol. 31, 1252\u20131262 (2011).","journal-title":"Mol. Cell Biol."},{"key":"27766_CR72","doi-asserted-by":"publisher","first-page":"4641","DOI":"10.1096\/fj.15-272732","volume":"29","author":"TJ Grevengoed","year":"2015","unstructured":"Grevengoed, T. J. et al. Loss of long-chain acyl-CoA synthetase isoform 1 impairs cardiac autophagy and mitochondrial structure through mechanistic target of rapamycin complex 1 activation. FASEB J. 29, 4641\u20134653 (2015).","journal-title":"FASEB J."},{"key":"27766_CR73","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1194\/jlr.M059717","volume":"56","author":"TJ Grevengoed","year":"2015","unstructured":"Grevengoed, T. J. et al. Acyl-CoA synthetase 1 deficiency alters cardiolipin species and impairs mitochondrial function. J. Lipid Res. 56, 1572\u20131582 (2015).","journal-title":"J. Lipid Res."},{"key":"27766_CR74","doi-asserted-by":"publisher","first-page":"25655","DOI":"10.1074\/jbc.M111.228692","volume":"286","author":"K Lee","year":"2011","unstructured":"Lee, K., Kerner, J. & Hoppel, C. L. Mitochondrial carnitine palmitoyltransferase 1a (CPT1a) is part of an outer membrane fatty acid transfer complex. J. Biol. Chem. 286, 25655\u201325662 (2011).","journal-title":"J. Biol. Chem."},{"key":"27766_CR75","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2337\/db13-1070","volume":"64","author":"LO Li","year":"2015","unstructured":"Li, L. O. et al. Compartmentalized acyl-CoA metabolism in skeletal muscle regulates systemic glucose homeostasis. Diabetes 64, 23\u201335 (2015).","journal-title":"Diabetes"},{"key":"27766_CR76","doi-asserted-by":"publisher","first-page":"16724","DOI":"10.1074\/jbc.RA118.004049","volume":"293","author":"PA Young","year":"2018","unstructured":"Young, P. A. et al. Long-chain acyl-CoA synthetase 1 interacts with key proteins that activate and direct fatty acids into niche hepatic pathways. J. Biol. Chem. 293, 16724\u201316740 (2018).","journal-title":"J. Biol. Chem."},{"key":"27766_CR77","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1194\/jlr.M072512","volume":"58","author":"EL Klett","year":"2017","unstructured":"Klett, E. L. et al. Long-chain acyl-CoA synthetase isoforms differ in preferences for eicosanoid species and long-chain fatty acids. J. Lipid Res. 58, 884\u2013894 (2017).","journal-title":"J. Lipid Res."},{"key":"27766_CR78","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.3389\/fimmu.2019.02410","volume":"10","author":"J Roelands","year":"2019","unstructured":"Roelands, J. et al. Long-chain Acyl-CoA synthetase 1 role in sepsis and immunity: perspectives from a parallel review of public transcriptome datasets and of the literature. Front. Immunol. 10, 2410 (2019).","journal-title":"Front. Immunol."},{"key":"27766_CR79","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1006\/geno.1994.1480","volume":"23","author":"U Janssen","year":"1994","unstructured":"Janssen, U. et al. Human mitochondrial 3,2-trans-enoyl-CoA isomerase (DCI): gene structure and localization to chromosome 16p13.3. Genomics 23, 223\u2013228 (1994).","journal-title":"Genomics"},{"key":"27766_CR80","doi-asserted-by":"publisher","first-page":"11646","DOI":"10.1128\/JVI.05605-11","volume":"85","author":"AL Rasmussen","year":"2011","unstructured":"Rasmussen, A. L. et al. Systems virology identifies a mitochondrial fatty acid oxidation enzyme, dodecenoyl coenzyme A delta isomerase, required for hepatitis C virus replication and likely pathogenesis. J. Virol. 85, 11646\u201311654 (2011).","journal-title":"J. Virol."},{"key":"27766_CR81","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/ni.3366","volume":"17","author":"M Nomura","year":"2016","unstructured":"Nomura, M. et al. Fatty acid oxidation in macrophage polarization. Nat. Immunol. 17, 216\u2013217 (2016).","journal-title":"Nat. Immunol."},{"key":"27766_CR82","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3389\/fcell.2015.00083","volume":"3","author":"RJA Wanders","year":"2016","unstructured":"Wanders, R. J. A., Waterham, H. R. & Ferdinandusse, S. Metabolic interplay between peroxisomes and other subcellular organelles including mitochondria and the endoplasmic reticulum. Front. Cell Developmental Biol. 3, 83 (2016).","journal-title":"Front. Cell Developmental Biol."},{"key":"27766_CR83","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S0022-2275(20)38332-2","volume":"30","author":"JA Gordon","year":"1989","unstructured":"Gordon, J. A., Figard, P. H. & Spector, A. A. Identification of the major metabolite of 12-HETE produced by renal tubular epithelial cells. J. Lipid Res. 30, 731\u2013738 (1989).","journal-title":"J. Lipid Res."},{"key":"27766_CR84","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1172\/JCI114550","volume":"85","author":"JA Gordon","year":"1990","unstructured":"Gordon, J. A., Figard, P. H. & Spector, A. A. Hydroxyeicosatetraenoic acid metabolism in cultured human skin fibroblasts. Evidence for peroxisomal beta-oxidation. J. Clin. Invest. 85, 1173\u20131181 (1990).","journal-title":"J. Clin. Invest."},{"key":"27766_CR85","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/S0301-472X(03)00260-1","volume":"31","author":"T Kitamura","year":"2003","unstructured":"Kitamura, T. et al. Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics. Exp. Hematol. 31, 1007\u20131014 (2003).","journal-title":"Exp. Hematol."},{"key":"27766_CR86","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.omtm.2019.10.004","volume":"16","author":"N Ipseiz","year":"2020","unstructured":"Ipseiz, N. et al. Effective in vivo gene modification in mouse tissue-resident peritoneal macrophages by intraperitoneal delivery of lentiviral vectors. Mol. Ther. Methods Clin. Dev. 16, 21\u201331 (2020).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"27766_CR87","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1007\/s00216-014-8377-4","volume":"407","author":"AI Ostermann","year":"2015","unstructured":"Ostermann, A. I., Willenberg, I. & Schebb, N. H. Comparison of sample preparation methods for the quantitative analysis of eicosanoids and other oxylipins in plasma by means of LC-MS\/MS. Anal. Bioanal. Chem. 407, 1403\u20131414 (2015).","journal-title":"Anal. Bioanal. Chem."},{"key":"27766_CR88","unstructured":"Kolde, R. Pheatmap: pretty heatmaps 2012."},{"key":"27766_CR89","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02092-0","volume":"8","author":"LC Davies","year":"2017","unstructured":"Davies, L. C. et al. Peritoneal tissue-resident macrophages are metabolically poised to engage microbes using tissue-niche fuels. Nat. Commun. 8, 2074 (2017).","journal-title":"Nat. Commun."},{"key":"27766_CR90","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.redox.2018.04.005","volume":"17","author":"M Redmann","year":"2018","unstructured":"Redmann, M. et al. Methods for assessing mitochondrial quality control mechanisms and cellular consequences in cell culture. Redox Biol. 17, 59\u201369 (2018).","journal-title":"Redox Biol."},{"key":"27766_CR91","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"27766_CR92","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1093\/bioinformatics\/btq431","volume":"26","author":"BS Carvalho","year":"2010","unstructured":"Carvalho, B. S. & Irizarry, R. A. A framework for oligonucleotide microarray preprocessing. Bioinformatics 26, 2363\u20132367 (2010).","journal-title":"Bioinformatics"},{"key":"27766_CR93","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1093\/bioinformatics\/btn224","volume":"24","author":"P Du","year":"2008","unstructured":"Du, P., Kibbe, W. A. & Lin, S. M. lumi: a pipeline for processing Illumina microarray. Bioinformatics 24, 1547\u20131548 (2008).","journal-title":"Bioinformatics"},{"key":"27766_CR94","unstructured":"Kreuger, F. Trim Galore. https:\/\/www.bioinformatics.babraham.ac.uk\/projects\/trim_galore\/ (2019)."},{"key":"27766_CR95","unstructured":"Andrews, S. FastQC. https:\/\/www.bioinformatics.babraham.ac.uk\/projects\/fastqc\/ (2019)."},{"key":"27766_CR96","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2012","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2012).","journal-title":"Bioinformatics"},{"key":"27766_CR97","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2013","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923\u2013930 (2013).","journal-title":"Bioinformatics"},{"key":"27766_CR98","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"27766_CR99","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.aca.2014.11.015","volume":"854","author":"J Han","year":"2015","unstructured":"Han, J. et al. An isotope-labeled chemical derivatization method for the quantitation of short-chain fatty acids in human feces by liquid chromatography-tandem mass spectrometry. Anal. Chim. Acta 854, 86\u201394 (2015).","journal-title":"Anal. Chim. Acta"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27766-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27766-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27766-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T10:28:16Z","timestamp":1669285696000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27766-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,10]]},"references-count":99,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["27766"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-27766-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.08.17.252007","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,10]]},"assertion":[{"value":"4 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"P.K. is an employee of Cayman Chemical. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"139"}}